RUCDR Infinite Biologics Receives $19M for NIDA Genetics Center | GenomeWeb

NEW YORK (GenomeWeb) – RUCDR Infinite Biologics, a unit of the Rutgers Human Genetics Institute of New Jersey, has received a $19 million contract from the National Institute on Drug Abuse to expand the service offerings it provides through the NIDA Center for Genetic Studies, the Rutgers Office of Research and Economic Development said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.